163 related articles for article (PubMed ID: 2568246)
1. Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer.
Savarino V; Mela GS; Zentilin P; Bonifacino G; Moretti M; Valle F; Celle G
Dig Dis Sci; 1989 Jul; 34(7):1043-6. PubMed ID: 2568246
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
[TBL] [Abstract][Full Text] [Related]
3. Overnight comparable anacidity by standard large and half-single bedtime doses of H2 antagonists in duodenal ulcer patients: a clinical pharmacological study.
Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P; Celle G
Am J Gastroenterol; 1988 Sep; 83(9):917-22. PubMed ID: 2901220
[TBL] [Abstract][Full Text] [Related]
4. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
5. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
6. The 24-hour acid suppression profile of nizatidine.
Dammann HG; Gottlieb WR; Walter TA; Müller P; Simon B; Keohane P
Scand J Gastroenterol Suppl; 1987; 136():56-60. PubMed ID: 2892256
[TBL] [Abstract][Full Text] [Related]
7. A double-blind randomized study comparing different dose regimens of H2-receptor antagonists on 24-hour gastric secretion in normal subjects and duodenal ulcer patients.
de Gara CJ; Burget DW; Silletti C; Hunt RH
Am J Gastroenterol; 1987 Jan; 82(1):36-41. PubMed ID: 3099564
[TBL] [Abstract][Full Text] [Related]
8. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Mela GS; Celle G
J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864
[TBL] [Abstract][Full Text] [Related]
9. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.
Jones DB; Howden CW; Burget DW; Kerr GD; Hunt RH
Gut; 1987 Sep; 28(9):1120-7. PubMed ID: 2890561
[TBL] [Abstract][Full Text] [Related]
10. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.
Gledhill T; Howard OM; Buck M; Paul A; Hunt RH
Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692
[TBL] [Abstract][Full Text] [Related]
11. Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg.
Savarino V; Mela GS; Zentilin P; Cutela P; Mele R; Celle G
J Clin Pharmacol; 1993 Jan; 33(1):70-4. PubMed ID: 8429117
[TBL] [Abstract][Full Text] [Related]
12. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.
Dammann HG; Gottlieb WR; Walter TA; Dreyer M; Müller P; Simon B; Keohane P
Hepatogastroenterology; 1986 Oct; 33(5):217-20. PubMed ID: 2879782
[TBL] [Abstract][Full Text] [Related]
13. Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring.
Savarino V; Mela GS; Zentilin P; Sumberaz A; Cutela P; Celle G
Digestion; 1991; 48(3):141-8. PubMed ID: 1916034
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of 24-hour acidity by nizatidine].
Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
[TBL] [Abstract][Full Text] [Related]
15. Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring.
Celle G; Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P
Scand J Gastroenterol; 1988 May; 23(4):385-90. PubMed ID: 2898167
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.
Walt RP; Male PJ; Rawlings J; Hunt RH; Milton-Thompson GJ; Misiewicz JJ
Gut; 1981 Jan; 22(1):49-54. PubMed ID: 6109686
[TBL] [Abstract][Full Text] [Related]
17. Treatment of duodenal ulceration in the United States.
Dyck WP; Cloud ML; Offen WW; Matsumoto C; Chernish SM
Scand J Gastroenterol Suppl; 1987; 136():47-55. PubMed ID: 2892255
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, randomized, double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease.
McCullough AJ
Am J Med; 1986 Oct; 81(4B):17-24. PubMed ID: 2877570
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine.
Savarino V; Mela GS; Scalabrini P; Fera G; Zentilin P; Sumberaz A; Celle G
Eur J Clin Pharmacol; 1988; 35(2):203-7. PubMed ID: 3191940
[TBL] [Abstract][Full Text] [Related]
20. Twenty-four-hour intragastric acidity following early evening or bedtime administration of roxatidine in duodenal ulcer patients.
Lazzaroni M; Sangaletti O; Bargiggia S; Bensi G; Canali A; Bianchi Porro G
Aliment Pharmacol Ther; 1996 Apr; 10(2):187-91. PubMed ID: 8730248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
